Detalles de la búsqueda
1.
Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.
Biol Blood Marrow Transplant;
20(10): 1544-52, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24923537
2.
Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.
Biol Blood Marrow Transplant;
20(8): 1121-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24727337
3.
Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.
Biol Blood Marrow Transplant;
19(8): 1159-66, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23660171
4.
High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients.
Int J Clin Pharmacol Ther;
51(9): 711-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23782584
5.
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.
J Clin Virol;
161: 105420, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913789
6.
Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid, and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture.
Int J Infect Dis;
117: 287-294, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149246
7.
Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.
Clin Pharmacokinet;
55(5): 525-50, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26563168
8.
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.
Clin Pharmacokinet;
55(5): 551-93, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26620047
9.
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients.
Cancer Chemother Pharmacol;
76(1): 85-96, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25983023
10.
Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.
Clin Cancer Res;
20(3): 754-63, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24218510
11.
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.
Cancer Chemother Pharmacol;
72(3): 607-18, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23907443
12.
Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.
J Clin Pharmacol;
53(3): 264-75, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23444282
13.
A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.
J Clin Pharmacol;
52(11): 1654-64, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22174435
Resultados
1 -
13
de 13
1
Próxima >
>>